SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vion (formerly Oncorx) interesting play on Gene Therapy -- Ignore unavailable to you. Want to Upgrade?


To: Jim Oravetz who wrote (254)8/1/2001 10:55:57 PM
From: Jim Oravetz  Read Replies (1) | Respond to of 370
 
Revenue $180,992 Net income (3,232,875) Avg shrs (basic) 26,190,356

2Q
Jim



To: Jim Oravetz who wrote (254)9/6/2001 12:35:00 PM
From: Dave  Read Replies (1) | Respond to of 370
 
Hey Jim, can you direct me toward any basic description of the different phases of clinical trials required for new medicines? I'm curious about how long it might be (worst, expected, and best case scenarios) until TAPET and Triapine could be approved and be available for prescription.

Dave